blue cross blue shield ppo glp 1 coverage Why we are changing of GLP-1 drugs for weight loss Digital health company Ro launches

Researchers found that 32% of patients with eating disorders report having used a weight loss injection at least once.

GLP-1 medications such as semaglutide typically begin affecting appetite within days, though meaningful weight loss usually emerges after 4 to 8 weeks of consistent treatment at therapeutic doses

FDA approves Foundayo (orforglipron) the first GLP-1 pill with no food restrictions

Each day includes nutritionally complete high-protein smoothies, cold-pressed juices and super shots, providing up to 170g of protein, 30g of fibre and daily vitamin and mineral intake from real, cold-pressed ingredients

Hims & Hers is launching a tracker of GLP-1 shortages to push back against the FDA's recent moves to end compounding copycats of the blockbuster drugs.

Discover real stories and practical solutions for GLP-1 Medications Side Effects on Mental Health